about
Morning blood pressure surge and target organ damage in newly diagnosed type 2 diabetic patients: a cross sectional study.Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study.Latent autoimmune diabetes of the adult: current knowledge and uncertaintyAccuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses.Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study.Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.Reproducibility of pulse wave analysis and pulse wave velocity in patients with type 2 diabetes.Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study.The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage.The J-curve limbo: how low can you go?Invasive validation of arteriograph estimates of central blood pressure in patients with type 2 diabetes.Objective measurements of activity patterns in people with newly diagnosed Type 2 diabetes demonstrate a sedentary lifestyle.Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients.Increased ambulatory arterial stiffness index and pulse pressure in microalbuminuric patients with type 1 diabetes.Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy.Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene.Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine.Evaluation of interarm blood pressure differences using the Microlife WatchBP Office in a clinical setting.Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes.Low Physical Activity Is Associated With Increased Arterial Stiffness in Patients Recently Diagnosed With Type 2 Diabetes.The cardiovascular system in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene.Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes.Glycemic variability is associated with reduced cardiac autonomic modulation in women with type 2 diabetes.Assessment of central blood pressure in patients with type 2 diabetes: a comparison between SphygmoCor and invasively measured values.Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness."Under pressure": but which modality?Reproducibility of the ambulatory arterial stiffness index in patients with type 1 diabetes mellitusPulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitusAmbulatory arterial stiffness index: a composite index reflecting arterial stiffness, blood pressure variability and patients' diurnal cycleErratum. Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes. Diabetes Care 2015;38:682-688The Authors Reply
P50
Q35859398-223705E2-A494-441C-A93D-5A72D180D59DQ37042240-DFCE54AA-6738-4553-9ADE-3893D515A79DQ38324198-653C8E39-93FB-40D7-A13F-E55A87670E7DQ38657037-ED03EA06-B075-45BA-A607-546CFF6E9F83Q38820566-AE04B1EF-F354-4B03-BF63-BCA759079BAAQ38908327-864C0A70-2902-4638-9013-8AAC23FD551AQ39400618-4E28072C-3815-4CDA-A121-B580D9FDD638Q39611332-76269921-223C-4F13-A148-6984E447BCC4Q40343696-BF447D35-C06F-43E6-90AC-19CDCFC3C6A7Q43627975-6ABA0218-9265-40D3-B8FB-C4088FF9C911Q44243191-D511021E-7533-49F1-B796-88CD2DF9312FQ45900088-6A8A852F-E7EB-4952-87F1-AA5191717056Q46138355-DE790377-5422-4A7B-BF01-EC6D96F91614Q46635845-D6F58C17-88FD-4D87-AEFF-F429EB26B8C8Q47826603-7B1E1E0F-96C1-497F-9ECD-40AE42E40375Q48104524-163E16EC-F36C-46D5-A6BE-5BEDA7592D63Q50865509-5A3151BB-180F-4911-9729-5C8B9AA3632EQ50991260-82C25592-8295-48D6-B56F-8EDD747EF84EQ51348524-A47D0905-63D5-4B6A-8786-141757408743Q51585681-AC817E53-612A-401F-88B7-2B4FD4F38A32Q51640737-AA9849DD-09C1-4C6E-99C9-224CBB0ED8BBQ51646324-E720001E-9C70-4473-8CA7-D80898B5024BQ51668286-64C769D8-BFC0-425B-BE65-AF6241C76D7DQ53660007-AED5AF48-5CD2-4982-92C7-9D7E637876EBQ54637330-75A1F9D8-7545-426D-95F0-CF4385DBDCFDQ79675808-629F620E-6DB3-489F-AB18-7B904D80CB49Q82355169-B4D6B2C1-E364-433B-AD9A-8019EE17ED05Q83576035-18262418-1097-47A7-A967-6E4C68172B52Q85075890-73281885-C8B7-44C3-B989-26D176C8B71DQ86544253-99ED49FD-74DD-4586-9FCE-042E9B98F0AAQ95412825-65B1533D-C15B-4E96-85E6-5756A28D6043
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Esben Laugesen
@ast
Esben Laugesen
@en
Esben Laugesen
@es
Esben Laugesen
@nl
Esben Laugesen
@sl
type
label
Esben Laugesen
@ast
Esben Laugesen
@en
Esben Laugesen
@es
Esben Laugesen
@nl
Esben Laugesen
@sl
prefLabel
Esben Laugesen
@ast
Esben Laugesen
@en
Esben Laugesen
@es
Esben Laugesen
@nl
Esben Laugesen
@sl
P106
P1153
25522067100
P31
P496
0000-0003-1782-1596